Related Experiment Videos

Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase

K Elenius1, C J Choi, S Paul

  • 1Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Oncogene
|June 3, 1999
PubMed

Insights

A newly discovered ErbB4 receptor tyrosine kinase isoform, ErbB4 CYT-2, lacks a key binding site for phosphatidyl inositol 3-kinase (PI3-K). This difference prevents ErbB4 CYT-2 from activating the PI3-K signaling pathway, unlike the ErbB4 CYT-1 isoform.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Biochemistry

Background:

  • Receptor tyrosine kinases (RTKs) are crucial regulators of cell behavior.
  • The epidermal growth factor (EGF) receptor family includes ErbB1-4.
  • ErbB4 binds neuregulins (NRG) and other EGF family members, initiating signal transduction cascades.

Purpose of the Study:

  • To identify and characterize novel isoforms of ErbB4.
  • To investigate the functional consequences of variations in the ErbB4 cytoplasmic domain.
  • To determine if ErbB4 isoforms differ in their ability to activate the phosphatidyl inositol 3-kinase (PI3-K) pathway.

Main Methods:

  • Reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect ErbB4 isoforms in human and mouse tissues.
  • Cloning and sequencing identified two ErbB4 isoforms: ErbB4 CYT-1 and ErbB4 CYT-2.
  • NIH3T3 cell lines overexpressing each isoform were created to study PI3-K binding and activity.

Main Results:

  • Two ErbB4 isoforms, ErbB4 CYT-1 and ErbB4 CYT-2, were identified, differing in a 16 amino acid sequence within the cytoplasmic domain.
  • ErbB4 CYT-2 lacks a putative PI3-K binding site present in ErbB4 CYT-1.
  • Tissue-specific expression patterns were observed for the two isoforms.
  • ErbB4 CYT-2 could not bind or activate PI3-K, even indirectly, upon NRG-1 stimulation, while ErbB4 CYT-1 could.

Conclusions:

  • A novel, naturally occurring ErbB4 isoform (ErbB4 CYT-2) lacks the cytoplasmic domain sequence essential for PI3-K pathway activation.
  • This deletion renders ErbB4 CYT-2 incapable of binding or activating PI3-K, distinguishing its signaling function from ErbB4 CYT-1.
  • The findings reveal differential regulation of intracellular signaling by ErbB4 isoforms.

Related Concept Videos